We are committed to fulfilling Stony Brook’s mission of excellence in research, and to advancing scientific knowledge to improve patient care and population health.
Participation in our clinical trials is always completely voluntary, and never interferes with the normal standards for patient care.
Our clinical trials enable us to use, in addition to established therapies, the newest and most advanced technologies and treatments — long before they are available to other physicians.
Patients participate in our clinical trials only after they receive a complete explanation of their options from their surgeon and surgical team.
We are currently conducting studies to better understand the molecular effects of surgery and lung cancer on the physiology of the brain.
Other studies are now being conducted in the areas of thoracic aortic disease and spinal cord ischemia, with the aim of developing a monitoring device to detect direct blood flow to the spinal cord.
Since 1999, we have been part of the American College of Surgeons Oncology Group (ACOSOG) in order to participate in multi-center clinical trials of thoracic surgery for the treatment of lung cancer and other cancers in the chest. Our surgeons' participation provides patients with the only available access to these trials in Suffolk County.
For more information about our current clinical trials, please email our department research coordinator Andreea Fodor, PhD, or call her at 631-444-8333.